Skip to Main Content

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment

Conditions

Addictive Behaviors | Mental Health & Behavioral Research | Obesity & Weight Control

What is the purpose of this trial?

Brief Summary:

Brief Summary: This study will compare the effectiveness of cognitive behavioral therapy (CBT), lisdexamfetamine (LDX), and the combination of CBT and LDX for the treatment of binge-eating disorder in patients with obesity. This is an acute treatment comparing CBT or LDX alone or in combination.

  • Trial with
    National Institute of Diabetes and Digestive & Kidney Diseases (NIDDKD)
  • Start Date
    03/21/2019
  • End Date
    08/30/2025
Trial Image

For more information about this study, contact:

Valentina Ivezaj

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/24/2019
  • Study HIC
    #2000022480